Precision Biologics to give presentation at CICON 2023, Milan, Italy – shares new NEO-201 data from current Phase 2 Clinical Trial

Precision Biologics announces that Massimo Fantini PhD, our Director of Research and Development, will deliver a Poster Presentation at the CRI-ENCI-AACR Seventh International Cancer Immunotherapy Conference in Milan, Italy CICON — International Cancer Immunotherapy Conference

Poster title: The anti-core 1 O-glycans targeting monoclonal antibody NEO-201 recognizes and reduces the quantity of naïve regulatory T cells in PBMCs of cancer patients

Place/Date/Time: Milan Convention Center (Allianz MiCo), Italy, on Friday September 22nd, 2023 (12:45-2:00 PM,) poster section B, poster #137.